ArticleAmerican journal of cancer research2022
Erratum: Two engineered site-specific antibody-drug conjugates, HLmD4 and HLvM4, have potent therapeutic activity in two DLL4-positive tumour xenograft models.
Shijing Wang et al.PubMed ↗Full text ↗
No numbers read from the abstract.